Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
S126106-1mg | 1mg | In stock | $130.90 | |
S126106-5mg | 5mg | In stock | $276.90 | |
S126106-10mg | 10mg | In stock | $420.90 | |
S126106-25mg | 25mg | In stock | $947.90 | |
S126106-50mg | 50mg | In stock | $997.90 | |
S126106-100mg | 100mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $1,662.90 |
Synonyms | AC-36369 | AKOS027254768 | 2-phenyl-naphtho[2,3-d]oxazole-4,9-dione | 2-PHENYLNAPHTHO[2,3-D]OXAZOLE-4,9-DIONE | MFCD26960957 | 2-phenyl-naphthoxazole-4,9-quinone | A917582 | GTPL12225 | SJB2043 | sjb2-043 | 2-phenylbenzo[f][1,3]benzoxazole-4,9-dione | CS- |
---|---|
Specifications & Purity | Moligand™, ≥98% |
Biochemical and Physiological Mechanisms | IC50 Value: 0.544 uM (USP1) SJB2-043 is one of analogs/derivatives of C527, which is a novel and potent USP1 (ubiquitin-specific protease 1) inhibitor. Cells were treated with SJB2-043 for 24 hrs and cell extracts were incubated with HA-Ub-VS, followed b |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | INHIBITOR |
Mechanism of action | Inhibitor of ubiquitin specific peptidase 1 |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
IUPAC Name | 2-phenylbenzo[f][1,3]benzoxazole-4,9-dione |
---|---|
INCHI | InChI=1S/C17H9NO3/c19-14-11-8-4-5-9-12(11)15(20)16-13(14)18-17(21-16)10-6-2-1-3-7-10/h1-9H |
InChi Key | CMYQQADDUUDCCA-UHFFFAOYSA-N |
Canonical SMILES | C1=CC=C(C=C1)C2=NC3=C(O2)C(=O)C4=CC=CC=C4C3=O |
Isomeric SMILES | C1=CC=C(C=C1)C2=NC3=C(O2)C(=O)C4=CC=CC=C4C3=O |
PubChem CID | 509070 |
Molecular Weight | 275.26 |
ChEMBL Ligand | CHEMBL3407552 |
---|---|
PubChem CID | 509070 |
CAS Registry No. | 63388-44-3 |
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
C2210188 | Certificate of Analysis | Dec 20, 2023 | S126106 |
C2210190 | Certificate of Analysis | Dec 20, 2023 | S126106 |
C2210191 | Certificate of Analysis | Dec 20, 2023 | S126106 |
C2210192 | Certificate of Analysis | Dec 20, 2023 | S126106 |
C2210193 | Certificate of Analysis | Dec 20, 2023 | S126106 |
C2210663 | Certificate of Analysis | Dec 20, 2023 | S126106 |
Solubility | insoluble in H2O; insoluble in EtOH; ≥6.68 mg/mL in DMSO |
---|
1. Mistry H, Hsieh G, Buhrlage SJ, Huang M, Park E, Cuny GD, Galinsky I, Stone RM, Gray NS, D'Andrea AD et al.. (2013) Small-molecule inhibitors of USP1 target ID1 degradation in leukemic cells.. Mol Cancer Ther, 12 (12): (2651-62). [PMID:24130053] |
2. Tan L, Shan H, Han C, Zhang Z, Shen J, Zhang X, Xiang H, Lu K, Qi C, Li Y et al.. (2022) Discovery of Potent OTUB1/USP8 Dual Inhibitors Targeting Proteostasis in Non-Small-Cell Lung Cancer.. J Med Chem, 71 (13): (1755-70). [PMID:36221183] |